Michael Williams
Overview
Michael represents clients in Foreign Sovereign Immunities Act (FSIA) and Anti-Terrorism Act (ATA) litigation, complex international arbitrations, defamation, and healthcare fraud litigations. His clients include financial services and healthcare companies, as well as individuals and large groups of individuals. He maintains a pro bono practice with a focus on child custody cases and assisting survivors of domestic violence.
Career & Education
- Supreme Court of the United States
Marshal’s Aide Supervisor, 2018–2019 - Department of Defense
Extern, U.S. Air Force Judge Advocate General’s Office 15th Wing, Joint Base Pearl Harbor-Hickam, U.S. Air Force, 2021 - United States District Court for the District of Columbia
Intern, Honorable Paul L. Friedman, 2020
- Supreme Court of the United States
- Suffolk University, B.S.,
Political Science and Philosophy
, 2015 - University of Michigan Law School, J.D., 2022
- Suffolk University, B.S.,
- District of Columbia
Michael's Insights
Client Alert | 3 min read | 02.22.24
A February 13, 2024 Federal Trade Commission blog post titled AI (and other) Companies: Quietly Changing Your Terms of Service Could Be Unfair or Deceptive follows previous posts promoting its larger initiative to oversee the growing use of AI. In this post, the FTC reminds companies developing AI products to be cautious whenever changing their privacy policies and to ensure that the changes are not made in unfair or deceptive ways.
Client Alert | 2 min read | 01.29.24
Client Alert | 3 min read | 11.17.23
Cybersecurity in Medical Devices: FDA Guidance and Product Liability Considerations
Client Alert | 4 min read | 10.23.23
Insights
Michael's Insights
Client Alert | 3 min read | 02.22.24
A February 13, 2024 Federal Trade Commission blog post titled AI (and other) Companies: Quietly Changing Your Terms of Service Could Be Unfair or Deceptive follows previous posts promoting its larger initiative to oversee the growing use of AI. In this post, the FTC reminds companies developing AI products to be cautious whenever changing their privacy policies and to ensure that the changes are not made in unfair or deceptive ways.
Client Alert | 2 min read | 01.29.24
Client Alert | 3 min read | 11.17.23
Cybersecurity in Medical Devices: FDA Guidance and Product Liability Considerations
Client Alert | 4 min read | 10.23.23
